- Home
- Equipment
- australasia
- clinical trial
Show results for
Refine by
Clinical Trial Equipment Supplied In Australasia
21 equipment items found
by:Chimeric Therapeutics based inCarlton South, AUSTRALIA
CHM 1101 (CLTX CAR T) is an optimized first-in-class CAR T cell therapy that uniquely utilizes Chlorotoxin (CLTX), a 36-amino acid peptide derived from deathstalker scorpion venom as its tumour targeting ...
Manufactured by:Avania based inBrunswick, AUSTRALIA
Medical device clinical trials require highly specialized knowledge and a customized approach. Avania has experience across all medical device classifications. Our team has more than 30 years of experience managing successful medical device clinical trials across more than 30 countries. ...
Manufactured by:Magellan based inBox Hill North, AUSTRALIA
Our product MAG200 has successfully completed Phase I/II of a clinical trials on the use of allogeneic (donor) off-the-shelf stem cell therapy for OA. The pivotal Phase III trial is planned to commence 2023. ...
Manufactured by:Avania based inBrunswick, AUSTRALIA
The right in vitro diagnostic (IVD) device can streamline clinical trials and expedite personalized patient care. We deliver world-class assistance for your IVD device development. We’ll help you build out effective research studies and protocols designed to validate algorithm reliability and ...
Manufactured by:Avania based inBrunswick, AUSTRALIA
Orthopedic trauma and disease can affect anyone, from the youngest patient to the octogenarian. At Avania, our team has a proven track record of success with clinical trials investigating novel and advanced orthopedic technologies. These trials have moved products forward through development. At the same time, and more importantly, they have ...
Manufactured by:Retimer - Re-Time Pty Ltd based inLonsdale, AUSTRALIA
Portable light therapy wearable (Includes 1 nosepiece, 1 USB – B Type cable). Light therapy with retimer involves exposure to blue-green light for 30-45 minutes consistently at a designated time each ...
Manufactured by:Lexington Medical, Inc. based inBedford, MASSACHUSETTS (USA)
The most innovative feature in the surgical stapling category. Like downshifting on a bicycle to pedal uphill, switching to AEON’s Thick Mode gear reduces firing force for improved staple formation and superior hemostasis in thick ...
Manufactured by:Cartherics Pty ltd based inNotting Hill, AUSTRALIA
This technology arms the patient’s own T cells with CARs, which enable them to “seek and destroy” cancer ...
Manufactured by:PolyActiva Pty Ltd. based inParkville, AUSTRALIA
Being developed to reduce the risk of Endophthalmitis following ocular (cataract) surgery. Clinical Investigation Stage: Phase ...
Manufactured by:Camurus AB based inLund, SWEDEN
FluidCrysta nanoparticles can resolve bioavailability issues for water and lipid-soluble pharmaceuticals or biodegradation-sensitive drugs, such as peptides and proteins. FluidCrystal nanoparticles are usually water-based and comprise a stable emulsion of nanoparticles with a liquid crystalline structure. Investigational medicinal products based on this technology are administered either ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
Manufactured by:Radiopharm Theranostics based inCarlton, AUSTRALIA
AVβ6 is the invention of internationally regarded integrin expert Professor Johannes Notni, formerly at the Technical University of Munich and now Professor at Essen University. ...
by:Cardiac Dimensions, Inc. based inKirkland, WASHINGTON (USA)
A completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients. The goal: Treat the condition—not just the symptoms. The Carillon System is designed to work with the natural structure and function of the heart to help treat the condition of FMR as well as the related symptoms. We believe the ...
Manufactured by:Orthocell Ltd. based inMurdoch, AUSTRALIA
Every year, millions of people suffer peripheral nerve injury as the result of motor vehicle, sporting or work-related incidents. Nerve injuries result in pain, numbness, burning or tingling, or complete paralysis of the affected limb. Many people with nerve injuries are unable to work or participate in their favourite sport, and even simple things like getting dressed or making a cup of coffee ...
Manufactured by:Orthocell Ltd. based inMurdoch, AUSTRALIA
Tendon injuries are one of the most common musculoskeletal complaints reported to general practitioners, with shoulder pain affecting more than 50% of adults over the age of 50. Mostly frequently, shoulder pain is the result of damage to the rotator cuff tendon. Rotator cuff tendon tears have a significant impact on the individual, not only affecting their ability to work or play sport, but also ...
Manufactured by:Mesoblast Ltd. based inMelbourne, AUSTRALIA
Revascor is a Phase 3 product candidate being developed as a treatment for both advanced and end-stage chronic heart failure ...
Manufactured by:Renishaw plc based inGloucestershire, UNITED KINGDOM
Novel chronic and acute catheter systems for direct delivery of therapeutics to the ...
by:Atmo Biosciences based inBox Hill, AUSTRALIA
A safe and accurate way of measuring the concentration of various gases at the source of production in the gastrointestinal tract (GI tract) in ...
Manufactured by:NeuroScientific Biopharmaceuticals Ltd. based inCottesloe, AUSTRALIA
Multiple indications with unmet medical need. “Our company goal is to create new products that reach their target in the brain and act as a protector against nerve cells injury. Currently, there are no approved drugs that can slow down or halt neurodegeneration. We believe that EmtinB has potential to bridge this gap and bring this breakthrough medicine to clinics, bringing new hope to ...
Manufactured by:BioDiem Ltd. based inSouth Melbourne, AUSTRALIA
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves out-licensing of the company’s platform technology to vaccine manufacturers for the production of intranasal vaccines for the prevention of seasonal and pandemic ...